Obida, Janeth M.
HRN: 15-41-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFUROXIME 1.5GM (VIAL)
11/22/2022
11/29/2022
IV
1.5g
Q8H
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes